Breaking the cycle: building vaccine manufacturing capacity in Africa

The COVID-19 pandemic had brought inequities in access to vaccines into sharp relief and highlighted the importance of manufacturing vaccines within low and middle-income countries. The road ahead has many challenges but with optimism and perseverance, I believe we can build a more sustainable vaccine ecosystem in Africa.

On November 8, 2002, Charlotte Barker, Editor, Vaccine Insights, spoke to Patrick Tippoo about building vaccine manufacturing capacity in Africa. This article has been written based on that interview.

Please enter your email to access content Read now